Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli

Diabetes

Volumn 62, Issue 1, 2013, Pages 299-308

  Hodgin, Jeffrey B ^a   Nair, Viji ^a   Zhang, Hongyu ^a   Randolph, Ann ^a   Harris, Raymond C ^b   Nelson, Robert G ^c   Weil, E Jennifer ^c   Cavalcoli, James D ^d   Patel, Jignesh M ^e   Brosius III, Frank C ^a   Kretzler, Matthias ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD36 ANTIGEN; COLLAGEN TYPE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOCORTICOID RECEPTOR; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 16; JANUS KINASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN FOS; PROTEIN KINASE FYN; PROTEIN MDM2; SCATTER FACTOR RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY BIOPSY; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ADULT; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE REGULATORY NETWORKS; HUMANS; JANUS KINASES; KIDNEY GLOMERULUS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; STAT TRANSCRIPTION FACTORS; STREPTOZOCIN;

EID: 84872047522     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1667     Document Type: Article

References (27)

1. U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
2. Brosius FC 3rd, Alpers CE, Bottinger EP, et al.; Animal Models of Diabetic Complications Consortium. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009;20:2503-2512
3. Schmid H, Henger A, Kretzler M. Molecular approaches to chronic kidney disease. Curr Opin Nephrol Hypertens 2006;15:123-129
4. Brosius FC, Khoury CC, Buller CL, Chen S. Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab 2010;5:51-64
5. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-S154
6. Cohen CD, Frach K, Schlöndorff D, Kretzler M. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002;61:133-140
7. Zhang H, Saha J, Byun J, et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol 2008;295:F1071-F1081
8. Zhang H, Schin M, Saha J, et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2010;299:F91-F98
9. Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006;17:2664-2669
10. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 2006;290:F214-F222
11. Wiggin TD, Kretzler M, Pennathur S, Sullivan KA, Brosius FC, Feldman EL. Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. Endocrinology 2008;149:4928-4937
12. Henger A, Kretzler M, Doran P, et al. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 2004;65:904-917
13. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408
15. Moll AG, Lindenmeyer MT, Kretzler M, Nelson PJ, Zimmer R, Cohen CD. Transcript-specific expression profiles derived from sequence-based analysis of standard microarrays. PLoS ONE 2009;4:e4702
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98: 5116-5121
17. Tian J, Patel JM. TALE: a tool for approximate large graph matching. In Proceedings of the 24th International Conference on Data Engineering, Cancun, Mexico, 2008. Washington, DC, IEEE Computer Society, p. 963-972
18. Takiyama Y, Harumi T, Watanabe J, et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism. Diabetes 2011;60:981-992
19. Vasko R, Koziolek M, Ikehata M, et al. Role of basic fi broblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts. Am J Physiol Renal Physiol 2009;296:F1452-F1463
20. Berthier CC, Zhang H, Schin M, et al. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 2009;58:469-477
21. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002;99:3892-3904
22. Mentzel S, Van Son JP, De Jong AS, et al. Mouse glomerular epithelial cells in culture with features of podocytes in vivo express aminopeptidase A and angiotensinogen but not other components of the renin-angiotensin system. J Am Soc Nephrol 1997;8:706-719
23. Advani A, Wiggins KJ, Cox AJ, Zhang Y, Gilbert RE, Kelly DJ. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy. Nephrology (Carlton) 2011;16:573-581
24. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003;52:1031-1035
25. White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002;51:3083-3089
26. Herman-Edelstein M, Thomas MC, Thallas-Bonke V, Saleem M, Cooper ME, Kantharidis P. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-b: a model for diabetic podocytopathy. Diabetes 2011;60:1779-1788
27. Ortiz-Muñoz G, Lopez-Parra V, Lopez-Franco O, et al. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 2010;21:763-772